Although the reduction in food intake after treatment with analog 1 did not reach statistical significance, the BW-reducing effects of the compound were surprisingly comparable to analog 2 ( Fig 2B , S1 Data ).
← all excerpts
Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity.
1
—
—